The below specifications apply to the BUP: Buprenorphine panels of the One Step Drug Tests. This includes the 1-panel One Step Buprenorphine Drug Test - plus any multi-panel drug test containing a BUP panel.
The following table lists compounds that are positively detected in urine by the BUP One Step Buprenorphine Test Strip at 5 minutes. Buprenorphine is the target compound.
Two hundred twenty-six (226) urine samples were obtained and tested with the BUP One Step Buprenorphine Test Strip andy by LC/MS. The results are summarized below:
|Neg.*||Neg. (<-25% Cutoff)||Near Cutoff Neg. (-25% Cutoff to Cutoff)||Near Cutoff Pos. (Cutoff to +25% Cutoff)||Pos. (>+25% Cutoff)||Agreement with LC/MS|
|BUP One Step Test Strip||Pos.||0||0||0||5||50||98% (55/56)|
Total agreement with LC/MS: 225/226 = >99%
* Negative samples were confirmed using LC/MS by pooling these samples into groups of 15.
A drug-free urine pool was spiked with Buprenorphine at the following concentrations: 0 ng/ml, 5 ng/ml, 7.5 ng/ml, 10 ng/ml, 12.5 ng/ml, 15 ng/ml and 20 ng/ml. The assay cutoff level of 10 ng/ml was selected to correlate with the LC/MS analysis cutoff for Buprenorphine. The result demonstrates 99% accuracy at 50% above and 50% below the cutoff concentration. The data are summarized below:
|Buprenorphine Concentration (ng/ml)||Percent of Cutoff||n||Visual Result|
A study was conducted at 3 physician's offices by untrained operators using 3 different lots of product to demonstrate the within run, between run and between operator precision. An identical panel of coded specimens containing no Buprenorphine, 25% Buprenorphine above and below the cutoff and 50% Buprenorphine above and below the 10 ng/ml cutoff was provided to each site. The following results were tabulated:
|Buprenorphine Concentration (ng/ml)||n||Site A||Site B||Site C|
A study was conducted to determine the cross-reactivity of the test with compounds in either drug-free urine or Buprenorphine positive urine. The following compounds show no cross-reactivity (were not detected positive) when tested with the BUP One Step Buprenorphine Test Strip at a concentration of 100,000 ng/ml.
|Non Cross-Reacting Compounds|
|4-Acetamidophenol; Acetone; Acetophenetidin; Acetylsalicylic acid; Albumin; Aminopyrine; Amitryptyline; Amobarbital; Amoxapine; Amoxicillin; dl-Amphetamine; Ampicillin; Apomorphine; Ascorbic acid; Aspartame; Atropine; Benzilic acid; Benzoic acid; Benzphetamine; Bilirubin; Brompheniramine; Buspirone; Caffeine; Cannabidiol; Cannabinol; Cimetidine; Chloral hydrate; Chloramphenicol; Chlordiazepoxide; Chloroquine; Chlorothiazide; d-Chlorpheniramine; dl-Chlorpheniramine; Chlorpromazine; Chlorproxithene; Cholesterol; Clomipramine; Clonidine; Cortisone; l-Cotinine; Creatinine; Cyclobarbital; Cyclobenzaprine; Deoxycorticosterone; l-Deoxyephedrine; l-Deprenyl; Dextromethorphan; Diazepam; Diclofenac; Diflunisal; Digoxin; 4-Dimethylaminoantipyrine; Diphenhydramine; Dicyclomine; 5,5-Diphenylhydantoin; Disopyramide; Doxylamine; Ecgonine; Ecgonine methyl ester; EDDP; EMDP; Efavirenz; Ephedrine; l-Ephedrine; l-Epinephrine; dl-Epinephrine; Erythromycin; B-Estradiol; Estrone 3-sulfate; Ethanol; Ethyl p-aminobenzoate; Etodolac; Famprofazone; Fenfluramine; Fenoprofen; Fentanyl; Fluoxetine; Furosemide; Gentisic acid; d-Glucose; Guaiacol glyceryl ether; Guaiacol glyceryl ether carbamate; Hemoglobin; Hydralazine; Hydrochlorothiazide; Hydrocodone; Hydrocortisone; Hydromorphone; o-Hydroxyhippuric acid; p-Hydroxymethamphetamine; p-Hydroxynorephedrine; 3-Hydroxytyramine (Dopamine); Hydroxyzine; Ibuprofen; Imipramine; Iproniazid; l-Isoproterenol; Isoxsuprine; Kanamycin; Ketamine; Ketoprofen; Labetalol; Levorphanol; Lidocaine; Lindane; Lithium carbonate; Loperamide; Maprotiline; Meperidine; Meprobamate; l-Methamphetamine; Methaqualone; Methadone; Methoxyphenamine; MDMA; Methylphenidate; Mephentermine; Metoprolol; Morphine 3-B-D-glucuronide; Morphine; Methyprylon; Nalidixic acid; Naloxone; Naltrexone; a-Naphthaleneacetic acid; Naproxen; Niacinamide; Nifedipine; Nimesulide; Norcodeine; Normorphone; Norethindrone; d-Norpropoxyphene; Noscapine; dl-Octopamine; Orphenadrine; Oxalic acid; Oxazepam; Oxolinic acid; Oxycodone; Oxymetazoline; Oxymorphone; Papaverine; Pemoline; Penicillin-G; Pentazocine; Pentobarbital; Perphenazine; Phencyclidine; Phenelzine; Pheniramine; Phenobarbital; Phenothiazine; Phentermine; l-Phenylephrine; B-Phenylethylamine; dl-Phenylpropanolamine; Prednisolone; Prednisone; 5-B-Pregnane-3a,17a,21-triol-20-one; Procaine; Promazine; Promethazine; d-Propoxyphene; dl-Propranolol; d-Pseudoephedrine; Quinacrine; Quinidine; Quinine; Ranitidine; Riboflavin; Salicylic acid; Secobarbital; Serotonin (5-Hydroxytryptamine); Sodium Chloride; Sulfamethazine; Sulindac; Temazepam; Tetracycline; Tetrahydrocortexolone; Tetrahydrocortisone 3-acetate; Tetrahydrozoline; Thebaine; Theophylline; Thiamine; Thioridazine; l-Thyroxine; Tolbutamide; cis-Tramadol; trans-2-Phenylcyclopropylamine; Trazodone; Trimethobenzamide; Triamterene; Trimipramine; Trifluoperazine; Trimethoprim; Tryptamine; dl-Tryptophan; Tyramine; dl-Tyrosine; Uric acid; Verapamil; Zomepirac|
Fifteen (15) urine samples with specific gravity ranges from 1.004 to 1.034 were spiked with Buprenorphine to the concentrations of 5 ng/ml, 15 ng/ml and 20 ng/ml. The BUP One Step Buprenorphine Test Strip was tested in duplicate using the fifteen neat and spiked urine samples. The results demonstrate that varying ranges of urinary specific gravity does not affect the test results.
The pH of an aliquoted negative urine pool was adjusted to a pH range of 5 to 9 in 1 pH unit increments and spiked with Buprenorphine to the concentrations of 5 ng/ml, 15 ng/ml and 20 ng/ml. The spiked, pH-adjusted urine was tested with the BUP One Step Buprenorphine Test Strip in duplicate. The results demonstrate that varying ranges of pH does not interfere with the performance of the test.